Skip to main content
Log in

Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

We have studied the relationship between the apolipoprotein E gene (APOE) and the development of myoclonus, tremors, rigidity and seizures in 168 patients with probable early-onset Alzheimer's disease (AD). There was a statistically significantly lower risk of tremor for carriers of the ɛ4 allele of APOE. This allele was also associated with an increased risk of myoclonus. Our findings suggest that there may be differences in progression and clinical appearance in early-onset AD related to the APOE genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Basun H, Grut M, Winblad B, Lannfelt L (1995) Apolipoprotein E4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 183:32–34

    PubMed  Google Scholar 

  2. Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopeze R, Roques P, Duara R, Rossor M, Mullan M (1995) Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's disease but is not causative. Am J Med Genet 60:1–6

    PubMed  Google Scholar 

  3. Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evan A, Berr C, Vidal O, Roques P, Gouriet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, E4 allele as a major risk factor for sporadic early and late-onset form of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3:569–574

    PubMed  Google Scholar 

  4. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7:180–184

    PubMed  Google Scholar 

  5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risk of death and Alzheimer's disease. Neurology 45:1323–1238

    PubMed  Google Scholar 

  6. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187–220

    Google Scholar 

  7. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M (1995) Gene dose of the ɛ4 allele apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37:596–604

    PubMed  Google Scholar 

  8. Hauser WA, Morris ML, Heston LL, Anderson VE (1986) Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36:1226–1230

    PubMed  Google Scholar 

  9. Hughes CP, Berg L, Danziger WL, Colen LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572

    PubMed  Google Scholar 

  10. Kurtzke JF (1989) On estimating survival; a tale of two censors. J Clin Epidemiol 42:169–175

    PubMed  Google Scholar 

  11. Samson WN, Van Duijn CM, Hop WCJ, Hofman A (1996) Clinical features and mortality in patients with early-onset Alzheimer's disease. Eur Neurol 36:103–106

    PubMed  Google Scholar 

  12. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L (1994) ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177:100–102

    PubMed  Google Scholar 

  13. Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bijlsma F (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 44:2300–2307

    PubMed  Google Scholar 

  14. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977–1981

    PubMed  Google Scholar 

  15. Van Duijn CM, Knijff P de, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 7:74–78

    PubMed  Google Scholar 

  16. Van Duijn CM, Knijff P de, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C (1995) The apolipoprotein E ɛ2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37:605–610

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cornelia M. van Duijn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bronzova, J., van Duijn, C.M., Havekes, L.M. et al. Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease. J Neurol 243, 465–468 (1996). https://doi.org/10.1007/BF00900501

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00900501

Key words

Navigation